4/A: BiomX Inc. Director Jonathan Leff Corrects Option Acquisition Report

Jonathan Leff, a director at BiomX Inc., files an amended Form 4 to correct an error in reporting the acquisition of derivative securities.

Summary

• Jonathan Leff, a director of BiomX Inc., filed an amended Form 4 with the SEC.
• The amendment corrects an administrative error in the original filing regarding the acquisition of common stock options.
• The error involved reporting the acquisition of 17,600 derivative securities under 'Disposed Of (D)' instead of 'Acquired (A)'.
• Leff holds these options for the benefit and at the direction of Deerfield Management Company, L.P., and disclaims beneficial ownership.
• The options vest over four years, starting April 14, 2026, with 25% vesting initially and the remainder in 12 equal quarterly installments.

Sentiment

Score: 7

Explanation: The document is a routine regulatory filing correcting a minor error. It doesn't indicate any fundamental changes in the company's prospects or financial health.

Management Comments

• The Reporting Person, a partner in Deerfield Management Company, L.P., has no pecuniary interest in the securities reported herein and disclaims beneficial ownership of such securities.
• The Reporting Person holds the options for the benefit, and at the direction, of Deerfield Management Company, L.P.

Industry Context

Form 4 filings are standard practice for reporting changes in beneficial ownership by company insiders, ensuring transparency and compliance with SEC regulations.

Key Dates

Keywords

Form 4, BiomX Inc., Jonathan Leff, derivative securities, stock options, beneficial ownership, Deerfield Management, amendment, SEC filing